| CONTACT: Richard R. Current,
Vice President & CFO ,
517/372-9200 |
Neogen wins trademark
lawsuit
LANSING, Mich., July 30, 2003 —
Neogen Corporation (Nasdaq: NEOG) announced today that a federal
court has ruled in its favor in a trademark infringement lawsuit
against Neo Gen Screening, a Pennsylvania-based company.
In his ruling following the trial,
Judge Robert Holmes Bell of the U.S. District Court for the Western
District of Michigan granted Neogen Corporation a permanent injunction
and ordered Neo Gen Screening to discontinue the use of the sequence
of letters “N E O G E N”. In addition to ruling that
Neo Gen Screening was infringing Neogen Corporation’s trademark,
the federal court also awarded Neogen Corporation its attorney fees
in connection with bringing the lawsuit.
Neogen Corporation was founded in
1982 and owns the federally registered trademark to “Neogen®”.
Its product line includes over 150 diagnostic test kits, including
those for the detection of metabolic disorders. Neo Gen Screening
began operations in 1994 and its laboratory provides screening for
metabolic disorders.
Neogen Corporation is a market leader
in developing and marketing products and services dedicated to food
and animal safety, and life sciences. The Company’s Food Safety
Division markets dehydrated culture media, and diagnostic test kits
to detect foodborne bacteria, natural toxins, genetic modifications,
metabolic disorders, food allergens, drug residues, plant diseases
and sanitation concerns. Neogen’s Animal Safety Division markets
a complete line of diagnostics, veterinary instruments, veterinary
pharmaceuticals, nutritional supplements, and life science tests
and reagents.
Certain portions of this news release
that do not relate to historical financial information constitute
forward-looking statements. These forward-looking statements are
subject to certain risks and uncertainties. Actual future results
and trends may differ materially from historical results or those
expected depending on a variety of factors listed in Management’s
Discussion and Analysis of Financial Condition and Results of Operations
in the Company’s most recently filed Form 10-K.
|